Strides had completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to USD 1.75 billion in December 2013.
Religare is bullish on Strides Arcolab Ind has recommended buy rating on the stock with a target price of Rs 1420 in its research report dated February 8, 2016. Religare is bullish on Strides Arcolab Ind has recommended buy rating on the stock with a target price of Rs 1420 in its research report dated February 8, 2016.
Strides is selling shares at Rs 1,278 apiece in the transaction, which comprises a base deal for Rs 100 crore with an upsize option of Rs 50 crore, IFR, a Thomson Reuters publication, said.
Religare is bullish on Strides Arcolab and has recommended buy rating on the stock with a target price of Rs 1570 in its research report dated December 15, 2015.
Paras Bothra of Ashika Stock Broking recommends buying Marico with a target of Rs 460 and KPIT Tech with a target of Rs 190.
Infosys | ICICI Bank | Mahindra and Mahindra | Thomas Cook | Arco Tech | Mahindra Holidays | MRPL | Intellect Design | IOC | Larsen and Toubro | GVK Power | LIC Housing Finance | Strides Arcolabs | Shree Renuka | Bajaj Hindusthan and Sakthi Sugars are stocks, which are in the news today.
According to Sudarshan Sukhani of s2analytics.com, Federal Bank is a short selling idea.
Gaurav Bissa of LKP Securities is of the view that advises selling Strides Arcolab.
Sudarshan Sukhani of s2analytics.com recommends buying Strides Arcolab and staying on the short side in Lupin.
Stocks likely to be in top 10 stocks are: State Bank of India, ABG Shipyard, Great Eastern Shipping Company, Cheviot Company, Gloster,Strides Arcolab, Dish TV India, Aurobindo Pharma, CESC, Glenmark Pharma, IDFC, Tata Consultancy Services.
Deepak Shenoy of Capitalmind.in likes Strides Arcolab for the long term.
Sudarshan Sukhani of s2analytics.com is of the view that Strides Arcolab may breakout.
Gaurav Ratnaparkhi of Sharekhan is of the view that one may buy Strides Arcolab with a target of Rs 1440.
Sudarshan Sukhani of s2analytics.com is of the view that one can go long in pharma stocks.
"The company has temporarily suspended the production, as directed by the government authorities," the company said in a filing to BSE.
The company has received approval from the US Food and Drug Administration (USFDA) to market Dutasteride capsules in the strength of 0.5 mg, Strides Shasun said in a regulatory filing.
Stocks that are likely to be in focus in today's trade are Vakrangee, Bharat Forge, Adani Ports and Special Economic Zone, Asian Paints, Vedanta, Hindalco Industries, Strides Arcolab, UPL, Advanta, Cheviot Company, Tata Motors and IDFC Bank.
SeQuent Scientific | Axis Bank | ONGC | Adani Ports | Asian Paints | Hindalco Industries and Vedanta are stocks, which are in the news today.
"S Abhaya Kumar has been appointed as Executive Director of the company with effect from November 19, 2015," Strides said in a filing to BSE.
Nitin Agrawal, Pharma & Real Estate Analyst at IDFC Securities says Sun Pharma and Dr Reddy‘s are attractive post their recent correction.
Ashish Kyal of avesstrategy.com feels that KEC International may test Rs 171.
Chandan Taparia of Anand Rathi Securities advises buying Strides Arcolab.
Stocks likely to be in focus are: Jet Airways, SpiceJet, Interglobe Aviation, Sun Pharmaceutical Industries, Vedanta, Hindalco Industries, Infosys, Dishman Pharmaceuticals & Chemicals, Godfrey Phillips India, Shree Renuka Sugars, EID Parry (India), Strides Arcolab, Emco.
Chandan Taparia of Anand Rathi Securities suggests buying Century Textiles and Strides Arcolab.
SP Tulsian of sptulsian.com feels that Wockhardt may move to Rs 2000.